ROSUVASTATIN Mepha cpr pell 20 mg 30 pce

7680664170078 CH-66417 C10AA07 07.12.0.

Reimbursement limitations:

ROSUVASTMeph

Chez les adultes de 18 à 75 ans, le traitement par statines est remboursé en …

ROSUVASTATIN Mepha cpr pell 20 mg 30 pce
ROSUVASTATIN Mepha cpr pell 20 mg 30 pce
ROSUVASTATIN Mepha cpr pell 20 mg 30 pce
1 / 3
google

Details

Product number
6641703
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
Tablette: rosuvastatinum 20 mg ut rosuvastatinum calcicum, cellulosum microcristallinum, lactosum monohydricum 195.94 mg, crospovidonum, hydroxypropylcellulosum, natrii hydrogenocarbonas corresp. natrium 0.27 mg, magnesii stearas, Überzug: lactosum monohydricum 4.4 mg, hypromellosum, triacetinum, E 171, E 172 (rubrum), pro compresso obducto.

Articles (1)

Rosuvastatin-Mepha 20 mg, Filmtablette
Filmtablette
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/10/2025
Patient information leaflet
Français
03/10/2025
Patient information leaflet
Italien
03/10/2025
Professional SmPC
Allemand
03/10/2025
Professional SmPC
Français
03/10/2025
Professional SmPC
Italien
03/10/2025

Detailed composition

Substance Quantity Type Category
TAB
20.0 MG Substance Wirkstoff (Principe actif)
TAB
- Substance WIZUS
TAB
- Substance HNIDK
TAB
195.94 MG Substance HBESI
TAB
- Substance HNIDK
TAB
- Substance HNIDK
TAB
- Substance HNIDK
TAB
0.27 MG Substance HBESI
TAB
- Substance HNIDK
TAB
2.312 MG Substance HBESI
TAB
- Substance HNIDK
TAB
- Substance FNIDK
TAB
- Substance HNIDK
TAB
- Substance FTODK

Reimbursement information

Public price
CHF 29.20
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2017

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66417
Drug name
Rosuvastatin-Mepha, Filmtablette
Galenic form
FILM
ATC Code
C10AA07
Authorization status
Z
Dispensation category
B
First authorization
18/04/2017
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration. Vorbeugung kardiovaskulärer Ereignisse bei Erwachsenen mit normalem LDL-Cholesterin Spiegel und erhöhtem Risiko von atherosklerotischen kardiovaskulären Erkrankungen

Packaging details

Description (FR)
ROSUVASTATIN Mepha cpr pell 20 mg 30 pce
Description (DE)
ROSUVASTATIN Mepha Filmtabl 20 mg 30 Stk
Market launch
18/04/2017
Narcotic (BTM)
No

Original drug

Crestor, Filmtabletten
GTIN: 7680561390067
CHF 29.50
View original

Other packaging sizes

ROSUVASTATIN Mepha cpr pell 5 mg 30 pce
30 TABL
GTIN: 7680664170016
View
ROSUVASTATIN Mepha cpr pell 5 mg 100 pce
100 TABL
GTIN: 7680664170023
View
ROSUVASTATIN Mepha cpr pell 5 mg bte 100 pce
100 TABL
GTIN: 7680664170030
View
ROSUVASTATIN Mepha cpr pell 10 mg 30 pce
30 TABL
GTIN: 7680664170047
View
ROSUVASTATIN Mepha cpr pell 10 mg 100 pce
100 TABL
GTIN: 7680664170054
View
ROSUVASTATIN Mepha cpr pell 10 mg bte 100 pce
100 TABL
GTIN: 7680664170061
View
ROSUVASTATIN Mepha cpr pell 20 mg 100 pce
100 TABL
GTIN: 7680664170085
View
ROSUVASTATIN Mepha cpr pell 20 mg bte 100 pce
100 TABL
GTIN: 7680664170092
View